Premium Nahrungsergänzungsmittel | artgerecht

Non-HDL Cholesterol: Meaning & Target Values

Non-HDL cholesterol includes all atherogenic lipoproteins in the blood and is a key risk marker for cardiovascular disease.

Regular tips about health Regular tips about health

Things worth knowing about "Non-HDL cholesterol"

Non-HDL cholesterol includes all atherogenic lipoproteins in the blood and is a key risk marker for cardiovascular disease.

What is Non-HDL Cholesterol?

Non-HDL cholesterol refers to the total amount of cholesterol carried by all lipoproteins in the blood except HDL (high-density lipoprotein), commonly known as “good cholesterol.” It is calculated simply by subtracting HDL cholesterol from total cholesterol. This single value captures all atherogenic – meaning artery-damaging – lipoproteins, including LDL cholesterol, VLDL cholesterol, IDL cholesterol, and lipoprotein(a).

Why is Non-HDL Cholesterol Important?

Compared to LDL cholesterol alone, non-HDL cholesterol provides a more complete picture of cardiovascular risk because it accounts for all potentially harmful lipoproteins. This is especially relevant for people with elevated triglycerides, type 2 diabetes, or metabolic syndrome, where LDL cholesterol may underestimate the true cardiovascular risk. In such cases, non-HDL cholesterol is considered a more reliable predictor of heart attack and stroke.

Calculation

The calculation is straightforward:

Non-HDL cholesterol = Total cholesterol − HDL cholesterol

An additional advantage is that non-HDL cholesterol can be reliably measured without fasting, as it is not directly affected by short-term fluctuations in triglyceride levels.

Normal Values and Target Levels

Recommended target values depend on an individual's cardiovascular risk profile. According to the European Society of Cardiology (ESC) guidelines, the following targets apply:

Low risk: Non-HDL cholesterol < 3.4 mmol/l (approx. 130 mg/dl)
Moderate risk: Non-HDL cholesterol < 3.4 mmol/l (approx. 130 mg/dl)
High risk: Non-HDL cholesterol < 2.6 mmol/l (approx. 100 mg/dl)
Very high risk (e.g., after heart attack, severe diabetes): Non-HDL cholesterol < 1.8 mmol/l (approx. 70 mg/dl)

As a general rule, the non-HDL target is approximately 0.8 mmol/l (30 mg/dl) higher than the corresponding LDL target.

Causes of Elevated Non-HDL Cholesterol

A high non-HDL cholesterol level can result from various factors:

Unhealthy diet high in saturated and trans fats
Physical inactivity and excess body weight
Type 2 diabetes and insulin resistance
Genetic lipid disorders (e.g., familial hypercholesterolaemia)
Hypothyroidism (underactive thyroid)
Chronic kidney disease
Certain medications (e.g., corticosteroids, some blood pressure drugs)

Diagnosis

Non-HDL cholesterol is determined as part of a standard lipid panel (blood lipid test). A blood sample is used to measure total cholesterol and HDL cholesterol, and the non-HDL value is then calculated. This test is part of routine cardiovascular prevention screening and is used by physicians to assess overall lipid-related risk.

Treatment and Reduction of Non-HDL Cholesterol

Lifestyle Modifications

A healthy lifestyle is the foundation of any treatment approach:

Diet low in saturated and trans fats, rich in fiber, vegetables, and unsaturated fatty acids
Regular physical activity (at least 150 minutes of moderate aerobic exercise per week)
Weight loss in cases of overweight or obesity
Smoking cessation and moderate alcohol consumption

Medication

If lifestyle changes are insufficient, the following medications may be prescribed:

Statins (e.g., atorvastatin, rosuvastatin): First-line treatment for lowering LDL and non-HDL cholesterol
Ezetimibe: Reduces cholesterol absorption in the intestine, often used in combination with statins
PCSK9 inhibitors (e.g., evolocumab, alirocumab): Highly effective antibody therapies for very high-risk patients
Fibrates: Primarily lower triglycerides and can also improve non-HDL cholesterol levels
Omega-3 fatty acids (high-dose, prescription-only): Used to treat very high triglyceride levels

References

Mach F et al. – 2019 ESC/EAS Guidelines for the management of dyslipidaemias. European Heart Journal, 2020; 41(1): 111–188.
Nordestgaard BG et al. – Fasting is not routinely required for determination of a lipid profile: clinical and laboratory implications including flagging at-risk individuals. European Heart Journal, 2016; 37(25): 1944–1958.
Ballantyne CM et al. – Non-HDL cholesterol as a predictor of cardiovascular disease. Current Cardiology Reports, 2014; 16(7): 499.

Building Blocks for a Healthy Life

As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.